This article summarises the recommendations of the new American Thoracic Society guidelines on the pharmacological management of chronic obstructive pulmonary disease, comments on how they differ from other guidelines, and considers the research needs and unanswered questions posed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12968/hmed.2020.0460 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!